InvestorsHub Logo
icon url

ariadndndough

02/25/13 9:09 PM

#26823 RE: Bxofscidad #26822

barry
yes he did. i think they are seeing some activity in EGFR and are still fine tuning the dose along with possible side effects. the bad news is we will have to wait until sept for the results. but that would be icing on the cake if that happens. and sept is not far off

i was very encouraged that there moving forward with a registration trial in ALK patients and not waiting. thats huge.

also loved hearing GIST is soon to be started. people are way underestimating this market. as PONA very well could be best in class drug here in huge market with a pretty fast pathway to market.